跳至主要内容
临床试验/NCT04568291
NCT04568291Unknown不适用

Clinical Reasearch on Three Dimensional Bionic Capture Network Circulating Tumor Cell in Lung Caner Patients With Bone Metastases

Shanghai 6th People's Hospital1 个研究点 分布在 1 个国家目标入组 160 人开始时间: 2020年10月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
160
试验地点
1
主要终点
SREs(Skeletal related events)

研究概览

简要总结

  1. Evaluate the feasibility of single cell sequencing technology based on three-dimensional bionic capture network;
  2. To build a risk prediction model of bone related events based on single cell sequencing;
  3. To verify the risk prediction model of bone related events by single cell sequencing;
  4. To verify the comprehensive treatment of non-small cell lung cancer ( NSCLC) bone metastases.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • age 18-75 years
  • pathology-proven diagnosis of lung cancer and radiographical/pathological evidence of BM
  • no previous treatment for BM
  • good general condition (Eastern Cooperative Oncology Group, ECOG Performance scores: 0-2) with an estimated survival time > 3 months.

排除标准

  • 未提供

研究组 & 干预措施

model treatment

Experimental

model treatment

干预措施: model treatment (Other)

routine treatment

Active Comparator

routine treatment

干预措施: routine treatment (Other)

结局指标

主要结局

SREs(Skeletal related events)

时间窗: 1 year

occurance of SREs,including bone pain, pathological fractures, spinal cord compression, hypercalcemia, and the need for surgery or radiotherapy

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Zhao Hui

Clinical Professor

Shanghai 6th People's Hospital

研究点 (1)

Loading locations...

相似试验